TCDA - Tricida announces $125M debt facility
- Tricida ( NASDAQ: TCDA ) on Wednesday announced a $125M debt facility with Hercules Capital ( HTGC ).
- Of the total amount, $100M will be available for drawdown at Tricida's ( TCDA ) option subject to meeting certain targets.
- $25M will be available for drawdown till Dec. 31, subject to announcement of positive data from the VALOR-CKD trial.
- Additional $25M will be available for drawdown until the earlier of 10 business days after the filing of the NDA for veverimer and Sept. 15, 2023.
- Additional $50M will be available for drawdown until the earlier of 10 business days after the FDA approves veverimer and Feb. 15, 2024.
- Additional $25M may be available through Dec. 15, 2024, subject to approval of by Hercules Capital ( HTGC ).
-
- Final maturity date for the debt facility is Nov. 1, 2025, which may be extended up to an additional two years.
For further details see:
Tricida announces $125M debt facility